A5051595274- Renal Transplantation Outcomes and Treatments
- Metabolism and Genetic Disorders
- Organ Transplantation Techniques and Outcomes
- Dialysis and Renal Disease Management
- Trace Elements in Health
- Pharmacological Effects and Toxicity Studies
- Neonatal Health and Biochemistry
- Organ Donation and Transplantation
- Silymarin and Mushroom Poisoning
- Complement system in diseases
- Poisoning and overdose treatments
- Pharmaceutical studies and practices
- Drug-Induced Hepatotoxicity and Protection
- Central Venous Catheters and Hemodialysis
- Blood groups and transfusion
- Global Health Care Issues
- Liver Disease and Transplantation
- Renal Diseases and Glomerulopathies
- Cytomegalovirus and herpesvirus research
- Childhood Cancer Survivors' Quality of Life
- Acute Kidney Injury Research
- Renal and Vascular Pathologies
- Cholesterol and Lipid Metabolism
- Apelin-related biomedical research
- Potassium and Related Disorders
Children's Memorial Health Institute
2001-2023
Instytut Matki i Dziecka
2000-2006
Data on comorbidities in children kidney replacement therapy (KRT) are scarce. Considering their high relevance for prognosis and treatment, this study aims to analyse the prevalence implications of European KRT.We included data from patients <20 years age when commencing KRT 2007 2017 22 countries within Society Paediatric Nephrology/European Renal Association Registry. Differences between with without access transplantation (KT) patient graft survival were estimated using Cox...
Abstract: FLF is a life‐threatening disease. Hepatic coma exerts dramatic impact on patient survival. At present, LTx the treatment modality of choice that provides significant improvement in outcome most patients with FLF. Multiple attempts have been made to reduce mortality and improve patient's condition. One new options AD – MARS. We present case 11‐yr‐old boy hepatic who avoided scheduled because rapid neurological biochemical immediately after three MARS sessions.
Prezentowane zalecenia są rozszerzoną i uaktualnioną wersją zaleceń pediatrycznych Polskiego Towarzystwa Nadciśnienia Tętniczego (PTNT) opublikowanych w 2015 roku. Od tego czasu ukazały się nowe opracowania wprowadzające między innymi nową klasyfikację nadciśnienia tętniczego, zasady postępowania grupach ryzyka oraz metody oceny uszkodzenia narządowego. W prezentowanych, zaktualizowanych zaleceniach PTNT uwzględniono zmiany wprowadzone European Society of Hypertension z 2016 roku wcześniej...
Pediatric patients with end-stage renal failure due to severe drug-resistant nephrotic syndrome are at risk of rapid recurrence after transplantation. Treatment options include plasmapheresis, high-dose cyclosporine A/methylprednisolone and more recently-rituximab (anti-B CD20 monoclonal depleting antibody). We report five immediate (1-2 days) post-transplant syndrome, treated this kind combined therapy including 2-4 weekly doses 375 mg/m(2) rituximab. Only two (of five) have showed full...
Abstract: We describe a case of multi‐organ failure (liver–kidney insufficiency and brain oedema) caused by accidental, acute intoxication with chromium copper‐containing substance, as an example the introduction new extracorporeal procedure MARS ( molecular adsorbents recirculating system ) in girl 3.5 years old.
Abstract aHUS is a clinical challenge for successful renal transplantation. Case report: A 14‐yr‐old girl lost her kidneys at the age of 7, due to CFH antibodies and CFH‐related protein ( CFHR 1/ 3) homozygous deletion‐associated aHUS. , CFI MCP gene mutations were excluded. The patient was candidate transplantation despite persistent presence (up 539 AU/mL). Treatment with MMF IVIG repeated PF (n = 8) introduced while being placed on urgent waiting list. Three years after onset, underwent...
SIOD is rare disorder related to SMARCAL1 or SMARCAL2 gene mutation, including (among other comorbidities) T-cell immunodeficiency, nephrotic syndrome, and renal failure. Up 22% of primary patients may develop various autoimmune disorders. We report the case 11-year-old male with SIOD, who presented ITP at 2 years after transplantation decrease in platelet count (from normal) 56 000/μL then (gradually) 2000/μL. There was no effect iv. methylprednisolone/dexamethasone. As presence antibodies...
Teisseyre, J; Markiewicz- Kijewska, M; Ismail, H; Szymczak, Prokurat, S; Jankowska, I; Ostoja-Chyyñska, A; Apanasiewicz, Kaliciñski, P Author Information